Want full text access to this journal?
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
Karen B Fowler, Shannon A Ross
No abstract text is available yet for this article.
November 7, 2019: Lancet Infectious Diseases
#2
Seilesh Kadambari, Andrew J Pollard, Michael J Goldacre, Raphael Goldacre
BACKGROUND: Congenital viral infections cause substantial long-term morbidity but population-based data about diagnosis rates are scarce. The aim of this study was to assess the long-term trends in congenital viral infections in England and to report on how the rates of these infections might have changed with improved methods for detection, the introduction of the two-dose measles-mumps-rubella (MMR) vaccine in 1996, and the implementation of the Newborn Hearing Screening Programme (NHSP) in 2006...
November 7, 2019: Lancet Infectious Diseases
#3
(no author information available yet)
No abstract text is available yet for this article.
November 6, 2019: Lancet Infectious Diseases
#4
REVIEW
Lawrence O Gostin, James G Hodge, Barry R Bloom, Ayman El-Mohandes, Jonathan Fielding, Peter Hotez, Ann Kurth, Heidi J Larson, Walter A Orenstein, Kenneth Rabin, Scott C Ratzan, Daniel Salmon
Vaccination is one of public health's greatest achievements, responsible for saving billions of lives. Yet, 20% of children worldwide are not fully protected, leading to 1·5 million child deaths annually from vaccine-preventable diseases. Millions more people have severe disabling illnesses, cancers, and disabilities stemming from underimmunisation. Reasons for falling vaccination rates globally include low public trust in vaccines, constraints on affordability or access, and insufficient governmental vaccine investments...
November 6, 2019: Lancet Infectious Diseases
#5
REVIEW
Oliver A Cornely, Ana Alastruey-Izquierdo, Dorothee Arenz, Sharon C A Chen, Eric Dannaoui, Bruno Hochhegger, Martin Hoenigl, Henrik E Jensen, Katrien Lagrou, Russell E Lewis, Sibylle C Mellinghoff, Mervyn Mer, Zoi D Pana, Danila Seidel, Donald C Sheppard, Roger Wahba, Murat Akova, Alexandre Alanio, Abdullah M S Al-Hatmi, Sevtap Arikan-Akdagli, Hamid Badali, Ronen Ben-Ami, Alexandro Bonifaz, Stéphane Bretagne, Elio Castagnola, Methee Chayakulkeeree, Arnaldo L Colombo, Dora E Corzo-León, Lubos Drgona, Andreas H Groll, Jesus Guinea, Claus-Peter Heussel, Ashraf S Ibrahim, Souha S Kanj, Nikolay Klimko, Michaela Lackner, Frederic Lamoth, Fanny Lanternier, Cornelia Lass-Floerl, Dong-Gun Lee, Thomas Lehrnbecher, Badre E Lmimouni, Mihai Mares, Georg Maschmeyer, Jacques F Meis, Joseph Meletiadis, C Orla Morrissey, Marcio Nucci, Rita Oladele, Livio Pagano, Alessandro Pasqualotto, Atul Patel, Zdenek Racil, Malcolm Richardson, Emmanuel Roilides, Markus Ruhnke, Seyedmojtaba Seyedmousavi, Neeraj Sidharthan, Nina Singh, János Sinko, Anna Skiada, Monica Slavin, Rajeev Soman, Brad Spellberg, William Steinbach, Ban Hock Tan, Andrew J Ullmann, Jörg J Vehreschild, Maria J G T Vehreschild, Thomas J Walsh, P Lewis White, Nathan P Wiederhold, Theoklis Zaoutis, Arunaloke Chakrabarti
Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality. Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and medical intervention is lifesaving. Guidance on the complex multidisciplinary management has potential to improve prognosis, but approaches differ between health-care settings. From January, 2018, authors from 33 countries in all United Nations regions analysed the published evidence on mucormycosis management and provided consensus recommendations addressing differences between the regions of the world as part of the "One World One Guideline" initiative of the European Confederation of Medical Mycology (ECMM)...
November 4, 2019: Lancet Infectious Diseases
#6
Matthew J Saunders, Tom Wingfield, Sumona Datta, Rosario Montoya, Eric Ramos, Matthew R Baldwin, Marco A Tovar, Benjamin E W Evans, Robert H Gilman, Carlton A Evans
BACKGROUND: The epidemiological impact and cost-effectiveness of social protection and biomedical interventions for tuberculosis-affected households might be improved by risk stratification. We therefore derived and externally validated a household-level risk score to predict tuberculosis among contacts of patients with tuberculosis. METHODS: In this prospective cohort study, we recruited tuberculosis-affected households from 15 desert shanty towns in Ventanilla and 17 urban communities in Callao, Lima, Peru...
October 30, 2019: Lancet Infectious Diseases
#7
Karen H Keddy
No abstract text is available yet for this article.
October 30, 2019: Lancet Infectious Diseases
#8
(no author information available yet)
BACKGROUND: Many countries have shown marked declines in diarrhoeal disease mortality among children younger than 5 years. With this analysis, we provide updated results on diarrhoeal disease mortality among children younger than 5 years from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) and use the study's comparative risk assessment to quantify trends and effects of risk factors, interventions, and broader sociodemographic development on mortality changes in 195 countries and territories from 1990 to 2017...
October 30, 2019: Lancet Infectious Diseases
#9
Carina King, Eric D McCollum
No abstract text is available yet for this article.
October 30, 2019: Lancet Infectious Diseases
#10
Jonathon R Campbell, Dick Menzies
No abstract text is available yet for this article.
October 30, 2019: Lancet Infectious Diseases
#11
(no author information available yet)
BACKGROUND: Despite large reductions in under-5 lower respiratory infection (LRI) mortality in many locations, the pace of progress for LRIs has generally lagged behind that of other childhood infectious diseases. To better inform programmes and policies focused on preventing and treating LRIs, we assessed the contributions and patterns of risk factor attribution, intervention coverage, and sociodemographic development in 195 countries and territories by drawing from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017) LRI estimates...
October 30, 2019: Lancet Infectious Diseases
#12
Sébastien Ds Pion, Hugues Nana-Djeunga, Yannick Niamsi-Emalio, Cédric B Chesnais, Hugo Deléglise, Charles Mackenzie, Wilma Stolk, Daniel A Fletcher, Amy D Klion, Thomas B Nutman, Michel Boussinesq, Joseph Kamgno
BACKGROUND: A test-and-not-treat (TaNT) strategy has been developed to prevent people with high concentrations of circulating Loa loa microfilariae (>20 000 microfilariae per mL) developing serious adverse events after ivermectin treatment during mass drug administration to eliminate onchocerciasis. An important question related to cost and programmatic issues is whether annual retesting is required for everyone. We therefore aimed to investigate changes in L loa microfilarial densities during TaNT campaigns run 18 months apart...
October 29, 2019: Lancet Infectious Diseases
#13
Jesica Herrick
No abstract text is available yet for this article.
October 29, 2019: Lancet Infectious Diseases
#14
Otavio T Ranzani, Laura C Rodrigues, Sidney Bombarda, Cátia M Minto, Eliseu A Waldman, Carlos R R Carvalho
BACKGROUND: Long-term survival and cause-specific mortality of patients who start tuberculosis treatment is rarely described. We aimed to assess the long-term survival of these patients and evaluate the association between vulnerable conditions (social, health behaviours, and comorbidities) and cause-specific mortality in a country with a high burden of tuberculosis. METHODS: In this population-based, longitudinal study in São Paulo state, Brazil, we described the 5-year survival of patients who were newly diagnosed with tuberculosis in 2010...
October 29, 2019: Lancet Infectious Diseases
#15
Barbara Reis-Santos, Marli Souza Rocha
No abstract text is available yet for this article.
October 29, 2019: Lancet Infectious Diseases
#16
Amee R Manges
No abstract text is available yet for this article.
October 22, 2019: Lancet Infectious Diseases
#17
Michaela J Day, Katie L Hopkins, David W Wareham, Mark A Toleman, Nicola Elviss, Luke Randall, Christopher Teale, Paul Cleary, Camilla Wiuff, Michel Doumith, Matthew J Ellington, Neil Woodford, David M Livermore
BACKGROUND: Extended-spectrum β-lactamase-producing Escherichia coli isolates (ESBL-E coli) cause more than 5000 cases of bacteraemias annually in the UK. The contribution of the food chain to these infections is debated. We aimed to identify the most important reservoirs of ESBL-E coli that colonise and infect humans to identify strategic intervention points. METHODS: Sampling for ESBL-E coli was done between Aug 1, 2013, and Dec 15, 2014. We used selective media to seek ESBL-E coli in routinely submitted samples from human faeces, and prospectively collected samples from sewage, farm slurry, and retail foodstuffs in London, East Anglia, northwest England, Scotland, and Wales...
October 22, 2019: Lancet Infectious Diseases
#18
Lucy B M Cook, Graham P Taylor
No abstract text is available yet for this article.
October 21, 2019: Lancet Infectious Diseases
#19
Gill Schierhout, Skye McGregor, Antoine Gessain, Lloyd Einsiedel, Marianne Martinello, John Kaldor
BACKGROUND: Human T-cell lymphotropic virus type 1 (HTLV-1) is a human retrovirus that causes a lifelong infection. Several diseases, including an aggressive form of leukaemia, have been designated as associated with HTLV-1, whereby having HTLV-1 is a necessary condition for diagnosis. Beyond these diseases, there is uncertainty about other health effects of HTLV-1. We aimed to synthesise evidence from epidemiological studies on associations between health outcomes and HTLV-1. METHODS: For this systematic review and meta-analysis, we searched Embase, MEDLINE, MEDLINE In-Process, and Global Health for publications from their inception to July, 2018...
October 21, 2019: Lancet Infectious Diseases
#20
Sophie A Valkenburg, Benjamin J Cowling
No abstract text is available yet for this article.
October 17, 2019: Lancet Infectious Diseases
Fetching more papers... 
